REGULATORISCHE NUKLEINSÄUREELEMENTE

European patent · EP2049671 · In force

Register entry

Publication number
EP2049671
Application number
EP07730192
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 15, 2007
Published
Apr 22, 2009
Granted
Dec 19, 2012
Protection ends at the latest
Jun 14, 2027
Next annual fee due
Jun 30, 2027
IPC classes
C07K 14/47 (2006.01)
C12N 15/63 (2006.01)
C12N 15/85 (2006.01)
C12N 15/67 (2006.01)
Priority
EP 06117862 26.07.2006
PCT application
PCT/EP2007/055954 15.06.2007
PCT publication
WO2008/012142 31.01.2008
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Dec 19, 2012

    Granted

    Published in Swissreg on 19.12.2012

Parties

Holder

Boehringer Ingelheim Pharma GmbH & Co. KG

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

ENENKEL, Barbara

88447 Warthausen, DE

SAUTTER, Kerstin

88400 Biberach, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.